AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06134518 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The education program
Description: The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).
Study NCT06134518 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: the initial orientation from the PHCs
Description: the initial orientation from the PHCs
Study NCT05687851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab（AK104）
Description: q3w iv
Study NCT05687851 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: EBRT
Description: 45-50.4Gy
Study NCT05961904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breastmilk
Description: Study group with receive orally 2 ml breast milk before the heel prick.
Study NCT05687851 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: BT
Description: ≥80Gy
Study NCT04945681 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Description: Mass campaign offering simultaneous pneumococcal conjugate vaccination to all children aged below 15 years of age living in Digaale camp, Somaliland. Children aged below 12 months receive 2 doses of vaccine, spaced 4 weeks apart. All other children receive one dose.
Study NCT05684237 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: HiSMILE treatment option
Description: The non-CE labeled VisuMax treatment option HiSMILE is able to modify the lenticule shape in a way that should lead to a change in spherical aberration postoperatively.
Study NCT05498610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0480 0389
Description: Participants will get 1 injections of NNC04800389. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days
Study NCT05498610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Participants will get 1 injections of semaglutide. It will be injected with a needle into a skin fold on the abdomen.~The study will last for a maximum of 72 days
Study NCT06486025 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: maintenance magnesium sulphate1g/h
Description: Women will receive a routine loading infusion of 5 g of MgSO4 over 20 minutes, followed by a maintenance dose rate of 1 g/h.
Study NCT06486025 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: maintenance magnesium sulphate2g/h
Description: Women will receive a routine loading infusion of 5 g of MgSO4 over 20 minutes, followed by a maintenance dose rate of 2 g/h.
Study NCT06477536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HB0034
Description: 300mg, i.v. Q4W
Study NCT05722873 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting arm
Description: Study participants will fast one day per week for 12 weeks
Study NCT05722873 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight maintenance
Description: Study participants will be counseled to maintain body weight
Study NCT05722873 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Counseling
Description: Study participants will be counseled on optimal diet and activity recommendations for maintaining/achieving a normal BMI
Study NCT05514977 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spine plane block
Description: Thoracic ESPB
Study NCT05003440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0385-0434
Description: Participants will get 1 tablet (oral use) of NNC0385-0434 per day for 10 days in either 15, 40 or 100 mg
Study NCT05003440 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will get 1 tablet (oral use) of placebo per day for 10 days
Study NCT06066450 — intervention group
Intervention type: DEVICE
Intervention: Genoss® DES system, Genoss® Osfit system
Description: This is a drug-eluting stent used to improve the diameter of the coronary artery in patients with symptomatic ischemic heart disease, with de novo lesions in the native coronary artery, where the reference vessel diameter ranges from 2.25mm to 5.00mm.
Study NCT05765162 — intervention group
Intervention type: BEHAVIORAL
Intervention: Patient reported ourcomes
Description: Full screening for the perioperative periode
Study NCT05274152 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Immersive Virtual Reality Lower Limb and Knee Rehabilitation
Description: Patients wore a VR headset while undergoing their rehabilitation session
Study NCT05274152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality Lower Limb and Knee Rehabilitation
Description: Patients wore a VR headset while undergoing their rehabilitation session
Study NCT06095700 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: first rib resection
Description: standard first rib resection
Study NCT06095700 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: First rib avulsion
Description: As the active treatment, just instead of resectioning the first rib, we will do an avulsion of the first rib through the same incision
Study NCT05308238 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention group
Description: Participants will receive 6 telehealth coaching sessions and 8 brief email or text check-ins over the course of 4 months. Participants will also receive a Fitbit and Engage PD Workbook.
Study NCT05308238 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disease management education group
Description: Participants will receive online educational videos that they can watch at their own convenience over the course of 4 months. There will be up to 6 hours of content, and the links to these online videos will be provided via email. Following completion of the study, individuals in this group will receive an Engage PD Workbook and one OT coaching session, if they choose to.
Study NCT06307899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unilateral Corner Stretch
Description: Individuals will be positioned in a standing position with the elbow in 90° flexion and the shoulder in 90° abduction, placing the palm on a flat surface. For stretching, individuals will be asked to increase shoulder horizontal abduction by rotating the trunk anteriorly and contralaterally. The position will be maintained for 30 seconds and will be repeated 4 times with a 30-second rest between repetitions.
Study NCT06307899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Stretching
Description: Individuals will be positioned supine with the shoulder in 90º abduction and external rotation and the elbow in 90º flexion. Stretching will be applied by the physiotherapist from just distal to the elbow in the direction of horizontal abduction of the shoulder. The position will be maintained for 30 seconds and will be repeated 4 times with a 30-second rest between repetitions.
Study NCT06307899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF Stretching
Description: Individuals will be in a sitting position with their hands clasped behind the head. The PM muscle will be stretched in the direction of horizontal abduction by placing the physiotherapist's hands anterior to the elbows. Passive stretching will be continued for 10 seconds, followed by 6 seconds of maximum voluntary isometric contraction of the PM muscle. The procedure will be repeated four times with 30 seconds of rest.
Study NCT05907278 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced Cooking Education
Description: Participants attend the ACE Program for 12 weeks after school.~On one assigned day of the week, participants attend ACE virtually. The session will begin with mindfulness exercises (15 minutes), professional development session (50 minutes), nutrition education lesson (20 minutes), and reflection period to talk about their experience in cooking lessons (25 minutes).~On any day during the week, the students will make a dish using groceries they received (1 hour).
Study NCT04924842 — intervention group
Intervention type: OTHER
Intervention: Review of medical file
Description: Review of medical patient file, including patient tracing, brief summary of the disease course, barrier gestures, social distancing.
Study NCT04924842 — intervention group
Intervention type: OTHER
Intervention: Phone call interview
Description: less than 15 minutes phone call
Study NCT05687526 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Telitacicept
Description: 12-17 years old: Telitacicept 2.5 mg/kg (with a maximum dose of 160 mg) subcutaneously once a week plus SOC for 12 weeks.~5-11years old: Telitacicept 3.0-3.5 mg/kg (with a maximum dose of 160 mg) subcutaneously once a week plus SOC for 12 weeks.
Study NCT05722574 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Romantic Competence Intervention
Description: Online, 30-minute self-administered relationship competence program for youth ages 16-20
Study NCT05722574 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information Only Control Condition
Description: Online, 30-minute self-administered relationship education activity for youth ages 16-20
Study NCT06265870 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Albendazole
Description: Participants receive empiric anthelminthic treatment which is albendazole 400 mg twice a day for seven consecutive days
Study NCT06265870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin or albendazole
Description: Participants will receive specific anthelminthic treatment tailored to the results of the stool tests
Study NCT06610058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument Assisted Soft Tissue Mobilization first Control second
Description: Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.
Study NCT06610058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control first Instrument Assisted Soft Tissue Mobilization second
Description: This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.
Study NCT06610071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICG administration
Description: The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group.
Study NCT06610071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICG administration
Description: The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg/patient in the second experimental group.
Study NCT06610071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICG administration
Description: The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group
Study NCT06610409 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood sampling
Description: Blood sample for CXCL5 Level
Study NCT06609772 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualised Pain Education
Description: Individualised Pain Education
Study NCT04681599 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Filter
Description: Filter is used to capture any individual bacteria or viruses that might be suspended within inhaled or exhaled gases
Study NCT04681599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Filter
Description: Filter is used to capture any individual bacteria or viruses that might be suspended within inhaled or exhaled gases
Study NCT04681599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scavenger face tent
Description: A face tent is connected to a vacuum resource to continuously suction the exhaled gas from the subject, in order to reduce the transmission risk of virus or bacteria
Study NCT05615493 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: radial extracorporeal shock wave therapy
Description: Radial extracorporeal shock wave therapy (r ESWT) will be applied by Dornier AR2 machine (Dornier MedTech GmbH, Wessling, Germany) under ultrasound guidance, at musculotendinous junction of medial and lateral head of the gastrocnemius for spastic calf (gastrocnemius muscle and the soleus) muscles . 1.500 pulses will be applied by an R20 probe with a focusing depth of 4cm.The intensity will be 0.10 mJ to 0.3mJ/mm2 (2.5 bar), with frequency 4 Hz every week for one month .No anesthetic or analgesic drugs will be administered to patients during the therapy session
Study NCT05615493 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham radial extracorporeal shock wave therapy
Description: Dornier AR2 machine (Dornier MedTech GmbH, Wessling, Germany) used under ultrasound guidance, at musculotendinous junction of medial and lateral head of the gastrocnemius for spastic calf (gastrocnemius muscle and the soleus) muscles . 1.500 pulses will be applied by an R20 probe with intensity of 0.10 mJ to 0.3mJ/mm2 (2.5 bar), \& frequency 4 Hz every week for one month without operating the machine .
Study NCT04871854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tocilizumab
Description: patients treated with Tocilizumab for Covid-19 infection
Study NCT04871854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: traditional Covid -19 therapy
Description: patients treated with traditional therapy for Covid-19 infection
Study NCT05203614 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Household Contribution
Description: Questionnaires
Study NCT05203614 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Outside Contribution
Description: Questionnaires
Study NCT05203614 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control
Description: Questionnaires
Study NCT05700669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AsiDNA
Description: All patients will receive a loading dose of AsiDNA intravenously (D1, D2, D3) followed by weekly intravenous administrations in combination with Olaparib.
Study NCT05700669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Olaparib is given orally in combination with AsiDNA
Study NCT05804838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness stress reduction program group
Description: Conscious Awareness Based Stress Reduction program will be applied to women in this group, which will last for 8 weeks. Informed Voluntary Consent Form, Descriptive Characteristics Information Form, Psychological Well-Being Scale, Beck Depression Scale, Prenatal Attachment Scale and Conscious Awareness Scale will be administered to the pregnant women who make up the intervention group before the implementation of the Mindfulness-Based Stress Reduction program. The intervention group will receive 1 session per week. Each session will last 80 minutes. After completing the 8-week MBSR program, data collection forms will be re-applied to the pregnant women in the intervention group and posttest-1 measurements will be made. After the posttest-1 measurements, the pregnants in the intervention group will be given posttest-2 measurements of the pregnants in the intervention group, 1 month after the measurements.
Study NCT05178810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FAB122
Description: Daily dose 100 mg
Study NCT05178810 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily dose
Study NCT06184516 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reproductive organ sparing radical cystectomy
Description: Participants on this arm will undergo a reproductive organ sparing radical cystectomy if they are classified as favorable based on the decision tool.
Study NCT06184516 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radical cystectomy
Description: Participants on this arm will undergo a radical cystectomy if they are classified as unfavorable based on the decision tool.
Study NCT06005194 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: InMotion
Description: A manualized physical activity counseling program that is based on the Diabetes Prevention Program (DPP) that has been adapted for TBI
Study NCT06005194 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: InMotion
Description: A manualized physical activity counseling program that is based on the Diabetes Prevention Program (DPP) that has been adapted for TBI
Study NCT06103500 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support Algorithm for Empiric Antibiotics in Sepsis
Description: A clinical decision support algorithm for empiric antibiotic selection in suspected infection.
Study NCT06119282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: inhaler
Description: Experimental: After the cesarean section, at the 8th hour postpartum, the VAS/GCA is evaluated, 4 drops of carrier oil are dropped on the upper and lower parts of the wick of the aroma stick, and then 15-20 drops of the prepared essential mixture are dropped and the woman is explained about its use. By the 8th hour of the postop, 4\*1 women are allowed to sniff. Before the application, the 30th and 60th minutes VAS/GOC, vital parameters are evaluated.
Study NCT06119282 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Control Group Pregnant women included in the control group will be left to clinical care, and pain and vital parameters will be monitored starting from the 8th postoperative hour. The scales applied to the experimental groups will be applied on the 2nd postoperative day. Women in the control group who completed the study will be informed about the postpartum use of aromatherapy. Women who want aromatherapy application will be directed to GETAT center.
Study NCT06119282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: massage
Description: Experimental: Test Massage When the studies conducted with the massage method are examined, back massage is applied for 10-30 minutes. Considering the working conditions of the institution, it is thought that a 10-minute massage may be sufficient for the application. The massage application is started at the postpartum 8th hour and applied for 10 minutes on the postoperative 0th day 1\*1, 2 times on the postoperative 1st and 2nd days when the woman feels ready. 30 and 60 minutes before application. then VAS/GCS, vital parameters are monitored.
Study NCT04882735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acoramidis
Description: TTR stabilizer administered orally twice daily (BID)
Study NCT05943964 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual exercise and rehabilitation program
Description: Participants will have two 30-minute sessions per week for 12 weeks. The program will focus on aerobic exercises and stretching exercises. When applicable, stretching exercises will focus on areas of contractures, and joints with limited range of motion (ROM).~Sessions will be completed by a team of Physical Therapists using the established telemedicine platform at Children's Healthcare of Atlanta, as used routinely in the blood and marrow transplant clinic for clinical care (Epic). Adherence to the program will be encouraged during monthly standard clinic visits.
Study NCT05552664 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: GIFT
Description: GIFT features a web-based intervention that offers access to an online family communication program containing key facts about genetics, cancer risk, and the role of genetic testing and helps patients share health information with their first-and second-degree relatives, whom they can invite to join the study to receive education/support and access to low-cost genetic testing.
Study NCT05710718 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PureWick™ System
Description: The PureWick™ FEC is intended for non-invasive urine output management in female patients. The PureWick™ FEC is a flexible, contoured external catheter that is positioned against the area where urine exits the female body. The PureWick™ FEC will be connected to the PureWick™ Urine Collection System (PUCS) via connector tubing. The PUCS uses suction (not felt by the user) to pull voided urine through the device, regardless of the urine flow rate. Urine continues through vinyl tubing until it reaches a collection canister, away from the body.
Study NCT05710718 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hollister® Female Urinary Pouch External Collection Device
Description: It is designed to be emptied and should be attached to a drainage bag. The FUP is made with hydrocolloid skin adhesive and polymer/copolymer plastics.
Study NCT04853173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assess pain management modalities in adult outpatient tonsillectomy surgery
Description: use a post-operative analgesia protocol suitable for outpatient surgery. Namely a protocol of analgesia based on the taking of drugs per bone (by mouth) and not intravenous. Pain evaluation.
Study NCT05991414 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home blood pressure monitor
Description: Participants provided home blood pressure monitor and instructions on use from pharmacist. They will measure home BP every 4-weeks for 7 days as per Hypertension Canada 7-day home BP protocol.
Study NCT05991414 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Enhanced community pharmacist care
Description: Pharmacist to follow up with participants every month to review home BP readings. Then the pharmacist will send home BP readings and recommendations for changes to antihypertensive medication regimen to participants prescribing clinician. Pharmacist will then advise participants to follow up with their prescribing clinician.